Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Zhejiang DSM Zhongken Biotechnology Co. Ltd. has 1 pending office action in the Chemistry & Materials technology area. The portfolio's current activity involves 1 distinct examiner and 1 distinct art unit. COHEN, STEFANIE J is the busiest examiner, with 1 pending office action under their review. This singular focus within the Chemistry & Materials sector suggests a highly targeted patent application or a portfolio in its earliest stages of development.
Practitioners should note that the prosecution strategy is currently centralized under this single examiner and art unit, which may lead to consistent feedback but offers no diversification of examiner perspectives. Because there is only 1 pending action, the company's immediate success in the Chemistry & Materials sector depends entirely on the outcome of this one case. Navigating the requirements of COHEN, STEFANIE J is the primary priority for the portfolio's current maintenance. This singular focus within 1 art unit simplifies the administrative tracking but increases the impact of any single examiner's decision on the overall portfolio. The company must ensure that its responses are perfectly tailored to the expectations of this specific examiner to avoid further delays.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COHEN, STEFANIE J | 1 | 75.5% | +2.5% |
| Art Unit | Apps |
|---|---|
| 1732 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18682570 | COMPOUND THICKENER AND APPLICATION THEREOF | COHEN, STEFANIE J | 1732 | §103 | Non-Final OA | — | Pending | Feb 09, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialZhejiang DSM Zhongken Biotechnology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Stefanie J Cohen has the most, with 1 of Zhejiang DSM Zhongken Biotechnology Co. Ltd.'s pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
